Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study
- PMID: 11106682
- DOI: 10.1093/jnci/92.23.1910
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study
Abstract
Background: Recent studies have suggested that men with elevated plasma levels of insulin-like growth factor-I (IGF-I) may have an increased risk of prostate cancer. Furthermore, IGF-binding proteins (IGFBPs) and insulin can modulate the activity of IGF-I. In this study, we sought to determine the role of IGF-I as well as IGFBPs-1, -2, and -3 and insulin as possible etiologic factors for prostate cancer.
Methods: We conducted a nested case-control study within the Northern Sweden Health and Disease Cohort Study. We measured levels of IGF-I, IGFBP-1, IGFBP-2, IGFBP-3, and insulin in plasma samples from 149 men who had a diagnosis of prostate cancer between 1 month and 10 years after blood collection and among 298 control men. All statistical tests are two-sided.
Results: Case subjects had statistically significantly higher mean levels of IGF-I than control subjects (229 ng/mL; 95% confidence interval [CI] = 218-240 ng/mL] versus 214 ng/mL [95% CI = 208-221 ng/mL]; P =.02) and IGFBP-3 (2611 ng/mL [95% CI = 2518-2704 ng/mL] versus 2498 ng/mL [95% CI = 2437-2560 ng/mL]; P =.04). Conditional logistic regression analyses showed increases in prostate cancer risk with rising levels of IGF-I (P:(for trend) =.02) and IGFBP-3 (P(for trend) =.03). In case subjects younger than 59 years at the time of blood collection, the risk associated with increased IGF-I was higher (P:(for trend) =.01), whereas the risk associated with increased IGFBP-3 was lower (P(for trend) =.44) than the corresponding risks in the full cohort. Prostate cancer risk was not associated with levels of IGFBP-1, IGFBP-2, or insulin.
Conclusions: Prostate cancer risk is increased in men with elevated plasma IGF-I. This association was particularly strong in younger men in this study, suggesting that circulating IGF-I may be specifically involved in the early pathogenesis of prostate cancer.
Comment in
-
Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.J Natl Cancer Inst. 2001 Apr 18;93(8):649-51. doi: 10.1093/jnci/93.8.649. J Natl Cancer Inst. 2001. PMID: 11309444 No abstract available.
Similar articles
-
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.Cancer Causes Control. 2017 Jun;28(6):497-528. doi: 10.1007/s10552-017-0883-1. Epub 2017 Mar 30. Cancer Causes Control. 2017. PMID: 28361446 Free PMC article. Review.
-
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.Ann Intern Med. 2008 Oct 7;149(7):461-71, W83-8. doi: 10.7326/0003-4819-149-7-200810070-00006. Ann Intern Med. 2008. PMID: 18838726 Free PMC article.
-
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600. doi: 10.1093/jnci/92.19.1592. J Natl Cancer Inst. 2000. PMID: 11018095
-
Insulin-like growth factor-I and binding protein-3 and risk of cancer.Horm Res. 1999;51 Suppl 3:34-41. doi: 10.1159/000053160. Horm Res. 1999. PMID: 10592442 Review.
-
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.J Natl Cancer Inst. 1998 Jun 17;90(12):911-5. doi: 10.1093/jnci/90.12.911. J Natl Cancer Inst. 1998. PMID: 9637140
Cited by
-
Synthetic Retinoids as Potential Therapeutics in Prostate Cancer-An Update of the Last Decade of Research: A Review.Int J Mol Sci. 2021 Sep 29;22(19):10537. doi: 10.3390/ijms221910537. Int J Mol Sci. 2021. PMID: 34638876 Free PMC article. Review.
-
Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer Risk.Cancer Prev Res (Phila). 2020 Oct;13(10):841-852. doi: 10.1158/1940-6207.CAPR-20-0236. Epub 2020 Jul 12. Cancer Prev Res (Phila). 2020. PMID: 32655006 Free PMC article. Clinical Trial.
-
Dietary Carcinogens and DNA Adducts in Prostate Cancer.Adv Exp Med Biol. 2019;1210:29-55. doi: 10.1007/978-3-030-32656-2_2. Adv Exp Med Biol. 2019. PMID: 31900903 Free PMC article. Review.
-
Association between insulin-like growth factor 1 gene rs35767 polymorphisms and cancer risk: A meta-analysis.Medicine (Baltimore). 2019 Nov;98(46):e18017. doi: 10.1097/MD.0000000000018017. Medicine (Baltimore). 2019. PMID: 31725675 Free PMC article.
-
Epidemiology of Prostate Cancer.World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20. World J Oncol. 2019. PMID: 31068988 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous